Skip to Main content Skip to Navigation
Journal articles

Quantitative evaluation of liver metastases density on computed tomography: A new tool to evaluate early response to bevacizumab-containing chemotherapy

Abstract : BACKGROUND:Response Evaluation Criteria in Solid Tumors (RECIST) are used to assess tumour shrinkage after cytotoxic chemotherapy, but may be inadequate for efficacy evaluation of anti-angiogenic therapies.AIMS:This study aimed to identify novel radiologic tumour response criteria based on early changes in tumour size and density, observed on computed tomography (CT), in patients with colorectal liver metastases (CRLM) treated with bevacizumab-containing chemotherapy.METHODS:CT of 71 and 68 CRLM patients treated with bevacizumab and non-bevacizumab-based regimens, respectively, were retrospectively reviewed. Tumour size, tumour density, and tumour-to-liver density (TTLD) ratio were determined at baseline and at first restaging. We tested their correlation with progression-free (PFS) and overall survival (OS) using the log-rank test.RESULTS:In the bevacizumab group, neither RECIST response nor tumour density variation was correlated with PFS or OS. In contrast, PFS and OS were significantly longer in patients with tumour size reduction ≥15% (RECIST-15%) and/or decrease in TTLD ratio not exceeding -10% (TTLD-10%) than in patients who did not reach any of those criteria, in univariate and multivariate analysis. Only size-response criteria predicted clinical outcome in the non-bevacizumab group.CONCLUSIONS:This study highlights new quantitative CT criteria that may early predict the efficacy of bevacizumab in CRLM patients.
Document type :
Journal articles
Complete list of metadata

https://hal.umontpellier.fr/hal-02452602
Contributor : Accord Elsevier Ccsd Connect in order to contact the contributor
Submitted on : Monday, October 25, 2021 - 4:47:42 PM
Last modification on : Wednesday, November 3, 2021 - 5:23:01 AM

File

S1590865819305341.pdf
Files produced by the author(s)

Licence


Distributed under a Creative Commons Attribution - NonCommercial 4.0 International License

Identifiers

Citation

Thibault Mazard, Eric Assénat, Marie Dupuy, Caroline Mollevi, Amandine René, et al.. Quantitative evaluation of liver metastases density on computed tomography: A new tool to evaluate early response to bevacizumab-containing chemotherapy. Digestive and Liver Disease, WB Saunders, 2019, 51 (8), pp.1185-1191. ⟨10.1016/j.dld.2019.03.028⟩. ⟨hal-02452602⟩

Share

Metrics

Record views

129

Files downloads

9